시장보고서
상품코드
1889609

세계의 바이러스 벡터 친화성 수지 시장 보고서(2025년)

Viral Vector Affinity Resin Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

바이러스 벡터 친화성 수지 시장 규모는 최근 급속히 확대되고 있습니다. 2024년의 5억 3,000만 달러에서 2025년에는 6억 2,000만 달러로, CAGR 16.4%로 성장하였습니다. 지난 수년간의 성장은 유전자 치료의 채택 확대, 백신 개발 수요 증가, 세포 치료 연구 투자 확대, 바이오 의약품 제조 확대, 바이러스 벡터 정제에 대한 관심 증가로 인해 발생하였습니다.

바이러스 벡터 친화성 수지 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 11억 3,000만 달러에 달하고, CAGR은 16.0%를 나타낼 전망입니다. 예측기간의 성장은 첨단 치료법에 대한 자금 증가, 바이러스 벡터의 임상시험 증가, 고순도 바이러스 벡터 수요 증가, CRO(수탁연구기관) 확대, 바이오프로세싱 기술에 대한 규제지원 강화로 인해 발생할 것으로 예측됩니다. 예측 기간의 주요 동향으로는 친화성 수지 설계의 기술적 진보, 바이러스 벡터 정제의 혁신, 확장 가능한 바이오프로세싱의 개발, 혈청형 특이적 수지의 연구 개발, 자동화 정제 시스템의 채용 등을 들 수 있습니다.

유전자 치료의 보급 확대가 향후 수년간 바이러스 벡터 친화성 수지 시장의 성장을 이끌 것으로 예측됩니다. 유전자 치료는 DNA, RNA 또는 바이러스 벡터를 이용하여 환자의 세포 내에서 유전자 발현을 변형 및 조절하는 첨단 치료법입니다. 유전 물질을 안전하고 효율적이며 표적 지향적으로 세포 내로 전달하는 전달 시스템의 개선으로 채택이 확대되고 있습니다. 바이러스 벡터 친화성 수지는 고순도의 확장 가능한 정제 솔루션을 제공함으로써 유전자 치료의 보급을 지원하고 바이러스 벡터 생산에 적합합니다. 불순물로부터 바이러스 벡터를 효과적으로 분리하여 다운스트림 공정의 과제를 저감하고, 생산 효율의 향상과 임상 및 상업 용도의 확대를 뒷받침합니다. 예를 들어 2024년 12월 미국 비영리 의료 과학 단체인 미국 유전자 및 세포 치료 학회(ASGCT)에 따르면 미국 식품의약국(FDA)은 2023년 6건의 유전자 치료 제품을 승인했습니다. 이는 2022년 5건에서 증가한 수치입니다. 따라서 유전자 치료의 채택 확대는 바이러스 벡터 친화성 수지 시장의 성장을 이끌고 있습니다.

향후 수년간 의료 지출 증가로 바이러스 벡터 친화성 수지 시장의 성장이 가속화할 것으로 예측됩니다. 의료 지출이란, 건강 상태의 유지 및 개선을 목적으로 한 의료 서비스, 치료, 시설, 연구, 공중 보건 시책에 대한 총 지출을 가리킵니다. 지출 증가의 배경에는 장기적으로 고액의 치료가 필요한 만성 질환의 유병률 상승이 있습니다. 의료 지출 증가는 첨단 바이오 제조 및 정제 기술에 대한 투자를 촉진함으로써 바이러스 벡터 친화성 수지 시장을 지원합니다. 유전자 치료 및 세포 치료에 대한 자금 투입 확대는 고품질 바이러스 벡터 생산 수요 증가로 이어집니다. 이 분야에서 친화성 수지는 효율적인 정제, 높은 수율 및 규제 기준과의 적합성을 제공합니다. 예를 들어 2024년 5월 영국 정부 기관인 국가 통계국(ONS)에 따르면 2023년 총 의료 지출은 명목 기준으로 5.6% 증가했으며 2022년 대비 0.9% 성장을 보였습니다. 따라서 의료 지출 증가가 바이러스 벡터 친화성 수지 시장의 성장을 견인하고 있습니다.

자주 묻는 질문

  • 바이러스 벡터 친화성 수지 시장 규모는 어떻게 변화하고 있나요?
  • 유전자 치료의 보급 확대가 바이러스 벡터 친화성 수지 시장에 미치는 영향은 무엇인가요?
  • 향후 바이러스 벡터 친화성 수지 시장의 성장 요인은 무엇인가요?
  • 바이러스 벡터 친화성 수지 시장의 주요 동향은 무엇인가요?
  • 바이러스 벡터 친화성 수지 시장의 주요 기업은 어디인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

  • 세계의 바이러스 벡터 친화성 수지 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
  • 최종 이용 산업의 분석
  • 세계의 바이러스 벡터 친화성 수지 시장 : 성장률 분석
  • 세계의 바이러스 벡터 친화성 수지 시장 실적 : 규모와 성장(2019-2024년)
  • 세계의 바이러스 벡터 친화성 수지 시장 예측 : 규모와 성장(2024-2029년, 2034F)
  • 세계의 바이러스 벡터 친화성 수지 시장 : 총 시장 규모(TAM)

제6장 시장 세분화

  • 세계의 바이러스 벡터 친화성 수지 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
  • 아데노바이러스 벡터 친화성 수지
  • 렌티바이러스 벡터 친화성 수지
  • AAV 벡터 친화성 수지
  • 레트로바이러스 벡터 친화성 수지
  • 기타 제품 유형
  • 세계의 바이러스 벡터 친화성 수지 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
  • 유전자 치료
  • 백신 개발
  • 세포 치료
  • 기타 용도
  • 세계의 바이러스 벡터 친화성 수지 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
  • 제약 및 생명공학기업
  • 학술연구기관
  • 수탁연구기관
  • 세계의 바이러스 벡터 친화성 수지 시장 세분화 : 아데노바이러스 벡터 친화성 수지, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
  • 세포 용해 기반의 아데노바이러스 벡터 친화성 수지
  • 크로마토그래피 기반의 아데노바이러스 벡터 친화성 수지
  • 고용량 아데노바이러스 벡터 친화성 수지
  • 프리팩 컬럼 아데노바이러스 벡터 친화성 수지
  • 세계의 바이러스 벡터 친화성 수지 시장 세분화 : 렌티바이러스 벡터 친화성 수지, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
  • 고순도 렌티바이러스 벡터 친화성 수지
  • 컬럼 기반 렌티바이러스 벡터 친화성 수지
  • 막 크로마토그래피 렌티바이러스 벡터 친화성 수지
  • 일회용 렌티바이러스 벡터 친화성 수지
  • 세계의 바이러스 벡터 친화성 수지 시장 세분화 : AAV 벡터 친화성 수지, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
  • 혈청형 특이적 AAV 벡터 친화성 수지
  • 고용량 AAV 벡터 친화성 수지
  • 프리팩 컬럼 AAV 벡터 친화성 수지
  • 리간드 기반 AAV 벡터 친화성 수지
  • 세계의 바이러스 벡터 친화성 수지 시장 세분화 : 레트로바이러스 벡터 친화성 수지, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
  • 고선택성 레트로바이러스 벡터 친화성 수지
  • 컬럼 기반 레트로바이러스 벡터 친화성 수지
  • 막 기반 레트로바이러스 벡터 친화성 수지
  • 프리팩 레트로바이러스 벡터 친화성 수지
  • 세계의 바이러스 벡터 친화성 수지 시장 세분화 : 기타 제품 유형별, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
  • 하이브리드형 바이러스 벡터 친화성 수지
  • 멀티모달 바이러스 벡터 친화성 수지
  • 재조합 리간드 친화성 수지
  • 맞춤형 바이러스 벡터 친화성 수지

제7장 지역별 및 국가별 분석

  • 세계의 바이러스 벡터 친화성 수지 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
  • 세계의 바이러스 벡터 친화성 수지 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

  • 바이러스 벡터 친화성 수지 시장 : 경쟁 구도
  • 바이러스 벡터 친화성 수지 시장 : 기업 프로파일
    • Thermo Fisher Scientific : 개요, 제품 및 서비스, 전략 및 재무 분석
    • GE Healthcare Technologies Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Repligen Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Creative Biolabs : 개요, 제품 및 서비스, 전략 및 재무 분석
    • JNC Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

  • Aptamer Group
  • ChromaGenix Inc.

제32장 세계 시장의 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

  • 바이러스 벡터 친화성 수지 시장(2029년) : 새로운 기회를 제공하는 국가
  • 바이러스 벡터 친화성 수지 시장(2029년) : 새로운 기회를 제공하는 부문
  • 바이러스 벡터 친화성 수지 시장(2029년) : 성장 전략
    • 시장 동향에 기초한 전략
    • 경쟁 전략

제36장 부록

CSM 26.01.06

Viral vector affinity resin is a specialized chromatography material created to selectively bind viral vectors based on specific surface proteins or capsid structures. It enables efficient purification of viral vectors from complex mixtures, removing impurities such as host cell proteins, DNA, and empty capsids, to produce high quality, high titer viral preparations for research or therapeutic use.

The main product types of viral vector affinity resin include adenoviral vector affinity resin, lentiviral vector affinity resin, adeno associated viral (AAV) vector affinity resin, retroviral vector affinity resin, and others. Adenoviral vector affinity resin is a specialized chromatography resin designed to selectively capture and purify adenovirus vectors based on their surface proteins or capsid structures. It is used in gene therapy, vaccine development, cell therapy, and other applications, serving end users such as pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The viral vector affinity resin market research report is one of a series of new reports from The Business Research Company that provides viral vector affinity resin market statistics, including viral vector affinity resin industry global market size, regional shares, competitors with a viral vector affinity resin market share, detailed viral vector affinity resin market segments, market trends and opportunities, and any further data you may need to thrive in the viral vector affinity resin industry. This viral vector affinity resin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The viral vector affinity resin market size has grown rapidly in recent years. It will grow from $0.53 billion in 2024 to $0.62 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to rising adoption of gene therapies, increasing demand for vaccine development, growing investment in cell therapy research, expansion of biopharmaceutical manufacturing, and increasing focus on viral vector purification.

The viral vector affinity resin market size is expected to see rapid growth in the next few years. It will grow to $1.13 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to rising funding for advanced therapies, a growing number of viral vector clinical trials, increasing demand for high purity viral vectors, expansion of contract research organizations, and rising regulatory support for bioprocessing technologies. Major trends in the forecast period include technological advancements in affinity resin design, innovations in viral vector purification, developments in scalable bioprocessing, research and development in serotype specific resins, and the adoption of automated purification systems.

The increasing adoption of gene-based therapeutics is expected to drive the growth of the viral vector affinity resin market in the coming years. Gene-based therapeutics are advanced treatments that use DNA, RNA, or viral vectors to modify or regulate gene expression within a patient's cells. Adoption is rising due to improvements in delivery systems that enable safe, efficient, and targeted transport of genetic material into cells. Viral vector affinity resin supports the adoption of gene-based therapeutics by providing high-purity, scalable purification solutions, making them suitable for viral vector production. They reduce downstream processing challenges by effectively isolating viral vectors from impurities, improving production efficiency and supporting broader clinical and commercial applications. For instance, in December 2024, according to the American Society of Gene & Cell Therapy, a US based non-profit medical and scientific organization, the Food and Drug Administration approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the growing adoption of gene-based therapeutics is driving the expansion of the viral vector affinity resin market.

The rising healthcare expenditure is expected to propel the growth of the viral vector affinity resin market in the coming years. Healthcare expenditure refers to the total spending on medical services, treatments, facilities, research, and public health initiatives aimed at maintaining or improving health outcomes. Increasing expenditure is driven by the rising prevalence of chronic diseases, which require long-term and often costly treatments. Higher healthcare spending supports the viral vector affinity resin market by promoting investment in advanced biomanufacturing and purification technologies. Greater funding for gene and cell therapies increases demand for high-quality viral vector production, where affinity resins provide efficient purification, higher yields, and adherence to regulatory standards. For example, in May 2024, according to the Office for National Statistics, a UK based government department, total healthcare expenditure rose by 5.6 percent in nominal terms in 2023, reflecting 0.9 percent growth compared to 2022. Therefore, the increase in healthcare expenditure is driving the growth of the viral vector affinity resin market.

In July 2024, Repligen Corporation, a US based biotechnology company, acquired Tantti Laboratory Inc. for an undisclosed amount. Through this acquisition, Repligen aims to enhance viral vector affinity resin capabilities and strengthen high-throughput purification solutions for emerging modalities such as viral vectors and nucleic acids by integrating Tantti's advanced DuloCore bead technology with Avitide's AVIPure affinity ligands. Tantti Laboratory Inc. is a Taiwan based biomaterials engineering company specializing in chromatography resins capable of purifying viral vectors.

Major companies operating in the viral vector affinity resin market are Thermo Fisher Scientific, GE Healthcare Technologies Inc., Repligen Corporation, Creative Biolabs, JNC Corporation, Aptamer Group, ChromaGenix Inc.

North America was the largest region in the viral vector affinity resin market in 2024. The regions covered in viral vector affinity resin report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the viral vector affinity resin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viral vector affinity resin market consists of sales of viral vector purification resins, pre-packed chromatography columns, ancillary purification kits, and consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viral Vector Affinity Resin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viral vector affinity resin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viral vector affinity resin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral vector affinity resin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Adenoviral Vector Affinity Resin; Lentiviral Vector Affinity Resin; Adeno-Associated Viral (AAV) Vector Affinity Resin; Retroviral Vector Affinity Resin; Other product types
  • 2) By Application: Gene Therapy; Vaccine Development; Cell Therapy; Other Applications
  • 3) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations
  • Subsegments:
  • 1) By Adenoviral Vector Affinity Resin: Cell Lysis-Based Adenoviral Vector Affinity Resin; Chromatography-Based Adenoviral Vector Affinity Resin; High-Capacity Adenoviral Vector Affinity Resin; Prepacked Column Adenoviral Vector Affinity Resin
  • 2) By Lentiviral Vector Affinity Resin: High-Purity Lentiviral Vector Affinity Resin; Column-Based Lentiviral Vector Affinity Resin; Membrane Chromatography Lentiviral Vector Affinity Resin; Single-Use Lentiviral Vector Affinity Resin
  • 3) By Adeno-Associated Viral Vector Affinity Resin: Serotype-Specific Adeno-Associated Viral Vector Affinity Resin; High-Capacity Adeno-Associated Viral Vector Affinity Resin; Prepacked Column Adeno-Associated Viral Vector Affinity Resin; Ligand-Based Adeno-Associated Viral Vector Affinity Resin
  • 4) By Retroviral Vector Affinity Resin: High-Selectivity Retroviral Vector Affinity Resin; Column-Based Retroviral Vector Affinity Resin; Membrane-Based Retroviral Vector Affinity Resin; Prepacked Retroviral Vector Affinity Resin
  • 5) By Other Product Types: Hybrid Viral Vector Affinity Resin; Multimodal Viral Vector Affinity Resin; Recombinant Ligand Affinity Resin; Customized Viral Vector Affinity Resin
  • Companies Mentioned: Thermo Fisher Scientific; GE Healthcare Technologies Inc.; Repligen Corporation; Creative Biolabs; JNC Corporation; Aptamer Group; ChromaGenix Inc.
  • Countries:

Table of Contents

1. Executive Summary

2. Viral Vector Affinity Resin Market Characteristics

3. Viral Vector Affinity Resin Market Trends And Strategies

4. Viral Vector Affinity Resin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Viral Vector Affinity Resin Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Viral Vector Affinity Resin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Viral Vector Affinity Resin Market Growth Rate Analysis
  • 5.4. Global Viral Vector Affinity Resin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Viral Vector Affinity Resin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Viral Vector Affinity Resin Total Addressable Market (TAM)

6. Viral Vector Affinity Resin Market Segmentation

  • 6.1. Global Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adenoviral Vector Affinity Resin
  • Lentiviral Vector Affinity Resin
  • Adeno-Associated Viral (AAV) Vector Affinity Resin
  • Retroviral Vector Affinity Resin
  • Other product types
  • 6.2. Global Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Therapy
  • Vaccine Development
  • Cell Therapy
  • Other Applications
  • 6.3. Global Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Academic And Research Institutes
  • Contract Research Organizations
  • 6.4. Global Viral Vector Affinity Resin Market, Sub-Segmentation Of Adenoviral Vector Affinity Resin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Lysis-Based Adenoviral Vector Affinity Resin
  • Chromatography-Based Adenoviral Vector Affinity Resin
  • High-Capacity Adenoviral Vector Affinity Resin
  • Prepacked Column Adenoviral Vector Affinity Resin
  • 6.5. Global Viral Vector Affinity Resin Market, Sub-Segmentation Of Lentiviral Vector Affinity Resin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Purity Lentiviral Vector Affinity Resin
  • Column-Based Lentiviral Vector Affinity Resin
  • Membrane Chromatography Lentiviral Vector Affinity Resin
  • Single-Use Lentiviral Vector Affinity Resin
  • 6.6. Global Viral Vector Affinity Resin Market, Sub-Segmentation Of Adeno-Associated Viral Vector Affinity Resin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serotype-Specific Adeno-Associated Viral Vector Affinity Resin
  • High-Capacity Adeno-Associated Viral Vector Affinity Resin
  • Prepacked Column Adeno-Associated Viral Vector Affinity Resin
  • Ligand-Based Adeno-Associated Viral Vector Affinity Resin
  • 6.7. Global Viral Vector Affinity Resin Market, Sub-Segmentation Of Retroviral Vector Affinity Resin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Selectivity Retroviral Vector Affinity Resin
  • Column-Based Retroviral Vector Affinity Resin
  • Membrane-Based Retroviral Vector Affinity Resin
  • Prepacked Retroviral Vector Affinity Resin
  • 6.8. Global Viral Vector Affinity Resin Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hybrid Viral Vector Affinity Resin
  • Multimodal Viral Vector Affinity Resin
  • Recombinant Ligand Affinity Resin
  • Customized Viral Vector Affinity Resin

7. Viral Vector Affinity Resin Market Regional And Country Analysis

  • 7.1. Global Viral Vector Affinity Resin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Viral Vector Affinity Resin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Viral Vector Affinity Resin Market

  • 8.1. Asia-Pacific Viral Vector Affinity Resin Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Viral Vector Affinity Resin Market

  • 9.1. China Viral Vector Affinity Resin Market Overview
  • 9.2. China Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Viral Vector Affinity Resin Market

  • 10.1. India Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Viral Vector Affinity Resin Market

  • 11.1. Japan Viral Vector Affinity Resin Market Overview
  • 11.2. Japan Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Viral Vector Affinity Resin Market

  • 12.1. Australia Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Viral Vector Affinity Resin Market

  • 13.1. Indonesia Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Viral Vector Affinity Resin Market

  • 14.1. South Korea Viral Vector Affinity Resin Market Overview
  • 14.2. South Korea Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Viral Vector Affinity Resin Market

  • 15.1. Western Europe Viral Vector Affinity Resin Market Overview
  • 15.2. Western Europe Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Viral Vector Affinity Resin Market

  • 16.1. UK Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Viral Vector Affinity Resin Market

  • 17.1. Germany Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Viral Vector Affinity Resin Market

  • 18.1. France Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Viral Vector Affinity Resin Market

  • 19.1. Italy Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Viral Vector Affinity Resin Market

  • 20.1. Spain Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Viral Vector Affinity Resin Market

  • 21.1. Eastern Europe Viral Vector Affinity Resin Market Overview
  • 21.2. Eastern Europe Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Viral Vector Affinity Resin Market

  • 22.1. Russia Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Viral Vector Affinity Resin Market

  • 23.1. North America Viral Vector Affinity Resin Market Overview
  • 23.2. North America Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Viral Vector Affinity Resin Market

  • 24.1. USA Viral Vector Affinity Resin Market Overview
  • 24.2. USA Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Viral Vector Affinity Resin Market

  • 25.1. Canada Viral Vector Affinity Resin Market Overview
  • 25.2. Canada Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Viral Vector Affinity Resin Market

  • 26.1. South America Viral Vector Affinity Resin Market Overview
  • 26.2. South America Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Viral Vector Affinity Resin Market

  • 27.1. Brazil Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Viral Vector Affinity Resin Market

  • 28.1. Middle East Viral Vector Affinity Resin Market Overview
  • 28.2. Middle East Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Viral Vector Affinity Resin Market

  • 29.1. Africa Viral Vector Affinity Resin Market Overview
  • 29.2. Africa Viral Vector Affinity Resin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Viral Vector Affinity Resin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Viral Vector Affinity Resin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Viral Vector Affinity Resin Market Competitive Landscape And Company Profiles

  • 30.1. Viral Vector Affinity Resin Market Competitive Landscape
  • 30.2. Viral Vector Affinity Resin Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Repligen Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Creative Biolabs Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. JNC Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Viral Vector Affinity Resin Market Other Major And Innovative Companies

  • 31.1. Aptamer Group
  • 31.2. ChromaGenix Inc.

32. Global Viral Vector Affinity Resin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viral Vector Affinity Resin Market

34. Recent Developments In The Viral Vector Affinity Resin Market

35. Viral Vector Affinity Resin Market High Potential Countries, Segments and Strategies

  • 35.1 Viral Vector Affinity Resin Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Viral Vector Affinity Resin Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Viral Vector Affinity Resin Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제